Eton Pharmaceuticals chief commercial officer Ipek Erdogan-Trinkaus reports sale of 3,500 common shares for $235,937.218
ETON•Eton Pharmaceuticals Chief Commercial Officer Ipek Erdogan-Trinkaus sold 3,500 common shares on Nov. 10, 2026, for a reported $235,937.218 and exercised options for 3,500 shares at $15.47 each.
1. Share transactions
Erdogan-Trinkaus sold 2,340 shares at $67.1787 each and 1,160 shares at $67.8785 each on Nov. 10, 2026. She also exercised employee stock options for 3,500 common shares at $15.47 per share.
2. Holdings after transactions
Following the transactions, her direct holdings totaled 4,081 common shares and 37,155 employee stock options.
